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Abstract: Health care demands have increased dramatically in recent decades. With the introduction of major changes in 
the management of health problems, health care costs have spiralled. Today, in the interests of cost control, medicine is 
geared towards outpatient care whenever possible. 
In this process, the medical community has been obliged to adapt its traditional criteria to the dictates of national econo-
mies. Today the criteria for the organization and evaluation of the health services are based on the concepts of efficacy, ef-
fectiveness and efficiency. This has led to the emergence of a new discipline for the design and evaluation of medical 
service production, known as servuction, an amalgam of “service” and “production”. The organigram of a new health 
product should include the problems the program faces and the steps proposed to overcome these problems. 
The concept of evaluation can be divided into two categories: administrative evaluation, and evaluative research. Avedis 
Donabedian was one of the founders of evaluative research, based on an easy-to-remember triad: structure-process-results. 
In the final evaluation of a new health care model, the innovations it provides must be considered. 
In this article we describe the stages involved in the design of a new health product and correlate them with the types of 
evaluation that should be applied at each point in the process. Our discussion addresses general aspects of servuction, but 
also focuses on the design of a particular service, created to care for patients with severe COPD. 
INTRODUCTION 
  Health care organization has evolved considerably in the 
last 20 years, on the one hand in order to respond to the 
growing needs and demands of the population and on the 
other due to the pressure to control expenditure in an area 
that devours financial resources. In countries with state 
health planning systems, the rationalization of the process 
aims to limit health expenditure and at the same time to 
channel it towards the areas most at need. This has led to 
controversy between doctors and health managers (on occa-
sion doctors who no longer practise, or doctors who may 
never in fact have practised at all). 
  In 1920, the Dawson report highlighted the importance of 
using epidemiological criteria in the design of the health 
services and the allocation of resources. The report also es-
tablished for the first time the concept of different levels of 
health care and proposed the creation of primary health care 
centres [1]. This radical vision was largely ignored in the 
literature and it was not until 1978 that the World Health 
Organization (WHO) acknowledged the importance of   
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primary care and defined accessibility, understanding, coor-
dination and continuity as its key features. Around the same 
time, Wennberg [2] found that the costs of hospital treatment 
were lower than those of outpatient care, identifying the need 
for an important qualitative change in the focus of a pub-
licly-funded health system. In the last century we have 
moved from a model in which health service consumption 
was predominantly hospital-based towards one in which ex-
penditure is increasingly channelled towards the primary 
care level [3]. This process has been slow but remorseless, 
and physicians have often been unaware of it. 
  The fact is that, whenever possible, medicine today is 
geared towards outpatient care, in order to increase the com-
fort of patients and families while attempting to keep expen-
diture down. The onus is gradually shifting onto primary 
care. This process cannot occur ad hoc, as has classically 
been the case in medicine (for instance, the development of a 
service, structure or practice to respond to specific needs as 
they arise) since it requires a high degree of interrelation 
between different care levels. A careful prior design is essen-
tial to ensure efficiency. This is the job of health planning 
and management and is a process in which doctors have an 
important part to play. 
  In Spain, a country with 40 million inhabitants, total 
health spending accounted for 8.2% of GDP in 2005, below 8    The Open Respiratory Medicine Journal, 2008, Volume 2  Domingo and Rubio 
the average of 9.0% in OECD countries. Health spending as 
a share of GDP is highest in the United States (which spent 
15.3% of its GDP on health in 2005), followed by Switzer-
land (11.6%), France (11.1%) and Germany (10.7%). Spain 
also ranks below the OECD average in terms of health 
spending per capita, with spending of 2255 USD in 2005 
(adjusted for purchasing power parity), compared with an 
OECD average of 2759 USD. Health management has three 
levels: macro, meso and micromanagement (Fig. 1) [4]. In 
the context of micro health management or clinical manage-
ment, doctors assign 70% of this total to their treatment deci-
sions [5,6]. This means that clinical management has tre-
mendous repercussions for the consumption of economic 
resources. The central problem facing the health services is 
to provide health professionals with the information they 
need to take cost-effective decisions and to encourage them 
to become involved in management, or clinical management, 
as it is now termed. 
 
Fig. (1). 
CRITERIA FOR ORGANIZATION AND DESIGN 
 Premises:  The current criteria for the organization and 
evaluation of the health services are based on the concepts of 
efficacy, effectiveness and efficiency. Efficacy measures the 
probability that an individual will benefit from a medical 
technology in ideal conditions. Broadly speaking, efficacy is 
useful to evaluate novel technologies and treatments. The 
tool used to determine it is the clinical trial. Like efficacy, 
effectiveness measures the probability that an individual will 
benefit from a medical technology, but this time in real, not 
ideal, conditions. This means that it will vary according to 
the organizational context and the society in question. The 
design most frequently used to determine effectiveness is the 
observational study. The concept of quality is linked to effi-
cacy and effectiveness: the smaller the difference between 
them, the higher the quality of the service. Finally, when we 
introduce the concept of economic evaluation of a service, 
we speak of efficiency. Some time ago, in 1974, Sir 
Archibald Cochrane [7] stated that while efficacy had not 
been widely studied, efficiency had received even less atten-
tion. 
 Organization:  A vital part of any assessment of health 
services (either new services, or those already in operation) 
is economic evaluation [8]. In the launch of any new service 
or product known today as servuction (an amalgam of the 
two key words, service and production) it is essential to have 
a clear conceptualization of the model and of its utility, of 
the services the new product aims to replace and at which 
levels, and to be fully aware that the new service is likely to 
entail a supplementary cost that must be budgeted for. 
LEVELS AND TYPES OF EVALUATION IN THE 
CREATION OF A NEW HEALTH PRODUCT 
  Evaluating involves issuing a judgement on a resource, 
activity or outcome, by applying a series of pre-established 
criteria or standards. Criteria are indicators or variables used 
to measure how far a) the objectives are fulfilled, b) the pro-
gram fits the objectives and c) the resources used are suffi-
cient. Standards are the level of reference of a criterion 
which allows an evaluation to be carried out. Evaluation is 
an ongoing process designed above all to correct and im-
prove aspects of the program in order to increase its effec-
tiveness, suitability and efficiency. Evaluation is a key ele-
ment in planning, design, management and decision-making, 
providing valuable information to allow modification of the 
program where necessary and to determine the program’s 
impact and outcomes. 
  The concept of evaluation can be divided into two cate-
gories. The first is administrative evaluation, which focuses 
on a particular aspect of the program, which aims to aid the 
decision-making process relating to specific resources or 
activities. Applying previously defined criteria and stan-
dards, administrative evaluation fine-tunes components of 
the program, checking or improving their functioning. The 
second is evaluative research which applies scientific meth-
ods to establish how, and how far, the interventions produce 
the desired effects. Its aims are to identify the effect of the 
programs or interventions, establish the validity of the stan-
dards and explain why a program succeeds or fails. 
  Evaluation can be applied both to technologies and to 
providers (see Fig. 2). The ultimate aim is to promote effica-
cious interventions and to conduct them effectively and ac-
curately in the right populations, seeking to achieve the 
greatest well-being possible while upholding the principle of 
fairness at all times. One problem with the evaluation of out-
comes is that they do not depend exclusively on the effec-
tiveness and efficiency of the technology or the provider, but 
also on the severity of patient’s condition. This means that in 
comparisons of several studies – a meta-analysis, for exam-
ple – the prerequisites needed for a correct evaluation are not 
always met. 
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  Avedis Donabedian was one of the founders of evalua-
tive research, based on an easy-to-remember triad: structure-
process-results (Fig. 3). The organigram of a servuction 
should also include the problems the program faces and the 
steps proposed to overcome these problems. Once the or-
ganigram is complete, the quality of each of the steps and 
components must be evaluated. Fig. 4 presents these steps 
graphically:  
a)  The first two steps refer to the planning and produc-
tion of a servuction:  
 Strategic  evaluation,  which establishes whether the 
program is indeed the best suited to solving the prob-
lem identified. Relates aims with problems. 
 Program  analysis, which establishes whether the 
program is correctly defined to solve the problem 
identified. Relates resources with aims. 
b)  The next four aim to improve its execution:  
  Evaluation of the difference, which establishes 
whether the program actually implemented corre-
sponds to the one that was planned, and whether the 
resources available correspond to the resources 
planned. 
  Evaluation of the structure (accreditation), which 
clarifies whether the resources are suitable for achiev-
ing the desired results, and establishes the fit between 
resources and standards. 
  Analysis of productivity, which examines whether 
optimal use has been made of the resources. Relates 
resources with processes. 
  Evaluation of the process (audit), which examines 
whether the activities proposed or conducted are ap-
propriate for achieving the desired results. Relates 
processes with standards. 
c)  The last two steps identify the effects of the servuction:  
  Analysis of efficiency, which assesses the relation 
between resources and results. 
  Analysis of efficacy and effectiveness, which evalu-
ates the results obtained with the servuction. Relates 
results with services. 
STRUCTURE OF THE ARTICLE 
  In this article we describe the stages involved in the de-
sign of a new health product and correlate them with the 
types of evaluation that should be applied at each point in the 
process. Our discussion will address general aspects of ser-
vuction, but will also focus on the design of a particular serv-
ice, created to care for patients with severe COPD. 
STAGES OF THE PROJECT 
1. Background - Previous Epidemiological Studies 
2. Hypothesis 
3. Aims 
4. Product Design - Conceptualization of the New Model 
5. Evaluation of the Suitability and Quality of the Servuction 
6. Clinical Design for Output Evaluation 
7. Implementation of the Model 
8. Output Evaluation. 
9. Conclusions. 
10. Innovations Contributed by the Study 
1. Background - Previous Epidemiological Studies (Stra-
tegic Evaluation) 
  1.1. Prevalence of COPD. The prevalence of chronic 
bronchitis (CB) is high, reaching 11.6% in our area of refer-
ence [9] and the prevalence of COPD was found to be 7.2% 
(Table 1) [9]. As this is a progressive disease in a high per-
centage of cases, a not insignificant number of these patients 
Fig. (3). 
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need home oxygen therapy (HOT) in the final stage of their 
disease. This treatment has proved its ability to increase life 
expectancy in these patients [10]. 
Table 1. Prevalence of COPD as a Function of Severity
1 
 
Degree of Bronchial Obstruction  Prevalence 
FEV1 < 80%  7.2% 
FEV1 < 75%  5.6% 
FEV1 < 70%  3.6% 
FEV1 < 65%  2.4% 
FEV1 < 50%  1% 
FEV1 < 35%  0.4% 
 
  1.2. Health expenditure deriving from chronic dis-
eases. It is well known today that health expenditure rises as 
a person ages and as life expectancy increases. In the US, 
health expenditure deriving from the consumption of health 
services due to acute processes increases more slowly than 
expenditure due to long-term care [11]. Therefore, health 
expenditure is likely to increase both due to the increase in 
life expectancy and to the long-term care requirements of the 
elderly population [11]. 
 1.3.  Current organizational model of health care in 
Catalonia. There is no clear model for patients with severe 
COPD, a high percentage of whom present respiratory insuf-
ficiency. Currently, care for these patients may take three 
different forms: a) primary care, with occasional visits to the 
hospital pneumologist; b) a mix of primary and in-hospital 
care; c) in-hospital care by the pneumologist. Given the ab-
sence of gatekeeping at different levels in the system, the 
first two sets of patients effectively form a single group. In 
practice this means that these patients generate a high num-
ber of unnecessary or avoidable visits at hospital emergency 
services (HES) which does not seem likely to fall in the short 
term in spite of the adoption of preventive measures [12]. 
  1.4. Increase in the use of hospital emergency services. 
The situation of HES care has been a matter of concern for 
many years for the health community and for society in gen-
eral. All developed countries have witnessed an increase in 
HES use, rising in Spain from 9.2 million visits in 1984 to 
15.3 million in 1994 [3]. To a large extent the increase can 
be attributed to a disproportionate rise in the number of pa-
tients making indiscriminate use of the HES and presenting 
with trivial complaints [3]. Patients tend to have more faith 
in the effectiveness of the HES services than of other areas 
in the health system such as primary care, which are often 
beset with serious organizational problems (see Table 2). 
  1.5. Comparison with alternative health models. Count-
ries in western Europe have made great efforts to design 
health care models that provide satisfactory clinical coverage 
at affordable cost. Numerous studies have compared the mer-
its of home care, hospital at home, primary or hospital-based 
care, or mixed models such as short hospitalization with early 
hospital discharge). 
  Among these models, home hospitalization programs are 
often considered to represent a cost-effective alternative to 
conventional hospitalization [30]. However, few studies have 
explored the issue in depth and the results are occasionally 
contradictory [31]. Coast and cols [31] attribute these con-
tradictions to the lack of reproducibility and comparability. 
Shepperd and cols published two studies in 1998 [32, 33] the 
first of which focused on the clinical viability of hospital at 
home and the second was a cost minimization study to assess 
its economic viability. COPD patients and patients conva-
lescing from a hysterectomy were the only ones who ex-
pressed preference for conventional hospitalization. In the 
second article, on cost minimization, they noted that hospital 
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at home for COPD patients was more expensive than con-
ventional hospitalization [33]. They concluded that home 
care of patients with a relatively high degree of independ-
ence seems to be cost-effective, although patients who re-
quire a high level of nursing care should be attended by 
means of conventional hospitalization. However, we cannot 
deny that hospital at home may in the future constitute a use-
ful complementary form of hospital care [34]. 
Table 2.  Percentage of Non-Urgent Cases Seen in Emergency 
Wards in Spain 
 
Study Year  % Non-Urgent Cases Seen in  
Emergency Wards  
Castillo
13 1986  58.6 
Muiño
14 1988  37 
Balanzo
15 1989    78.9 
Diego
16 1990  35 
Ibañez
17 1991    44.9 
Rodriguez
18 1992  65 
Anton
19 1992  65 
Alonso
20 1993    47.9 
Cubero
21 1994  60 
Marco
22 1994  55 
Gonzalez-Grajera
23 1995    49.5 
Lapeña
24 1996  69 
Sansa
25 1996    56-72 
Llorente
26 1996    24.1 
Escobedo
27 1997    54.7 
Oterino
28 1999    26.8 
Sempere
29  1999   29.6 
 
2. Hypothesis 
  The null hypothesis is that the design of a servuction for 
providing care for patients with COPD and respiratory insuf-
ficiency, using evidence-based medicine techniques, can’t: a) 
Improve patients’ clinical symptoms and quality of life. b) 
Reduce the costs of care for the financer and provider [35]. 
3. Aims 
I-  To design a specific, novel servuction for patients 
with severe COPD using evidence-based medicine 
techniques. 
II-  To evaluate the design of the servuction. 
III-  To evaluate the repercussion of the new service for: 
a) effectiveness ; b) quality of life; c) efficiency: eco-
nomic costs for the service supplier (the hospital) and 
for the financer (the Catalan Health Service, SCS). 
4. Product Design - Conceptualization of the New Model 
4.1. Conceptualization 
  To design a new model of medical care for patients with 
chronic respiratory failure (CRF) following COPD, so as to 
reduce a) the number of unnecessary visits in primary care 
centres, other hospital departments and the emergency serv-
ices at the CPT and b) the number of hospitalizations. 
  In the design of the servuction, we follow the principles 
described by Eiglier [8] and apply the evidence-based medi-
cine techniques supported by the Cochrane Collaboration. 
4.2. Features of the Servuction (Program Analysis and 
Evaluation of the Differences) 
 4.2.1.  Clients. To avoid service overload, the target popu-
lation was defined as patients with CRF after COPD in our 
area of reference. 
  We defined clearly that the servuction was aimed at pa-
tients with chronic respiratory failure (CRF) only following 
COPD. 
 4.2.2.  Physical  support. Material support and environment. 
 4.2.2.1.  Material  support. Consumables required. 
  The treatment required the use of a spirometer, a 
gasometer and a hemoxymeter from the functional assess-
ment unit of the hospital’s pneumology service. By avoiding 
the doubling up of materials and spaces, we also develop 
economies of scale. 
  4.2.2.2. Environment. The location of the service. 
  Patients were seen in an office on the first floor of the 
Taulí building at the CPT, next to the respiratory function 
assessment lab. The office should be on the same floor as the 
assessment lab, to keep patient movement to a minimum - 
these elderly patients have considerable walking difficulties 
due to their dyspnea-. 
 4.2.3.  Contact  personnel. A junior physician and a nurse 
from the functional assessment unit. 
  The program did not incur any extra expenditure for the 
CPT. 
4.3. Capacity of the Servuction (Accreditation) 
  4.3.1. Calculation of the number of potential beneficiar-
ies. The capacity of the new service, that is, the potential 
number of clients, should be calculated. This is a critical 
point. Just as in a clinical trial, the “sample size” should be 
estimated, even though in this case the aim is not to evaluate 
a variable of efficacy but to evaluate the minimum and 
maximum number of patients to attend. Obviously the figure 
will differ if we accept all patients with COPD or those with 
COPD and CRF. 
  Using data from our own studies [9, 36] we determined 
that the prevalence of chronic home oxygen therapy (HOT) 
had fallen from 94 to 63 /100,000 inhabitants [36] between 
1991 and 1995. This meant that there were 223 patients on 
the HOT program in our area, of whom 164 were followed at 
the hospital and the other 59 by a pneumologist at an outpa-
tient service not attached to the our hospital. We then deter-
mined the number of frequently hospitalized patients (those 
admitted to hospital three times a year or more); the total 
was 92. Finally a group of patients who did not require HOT 
but who might do so in the short or medium term were also 
included as possible candidates. We estimated this figure to 
be around 50% of those included on the HOT program (111 
in the entire reference area). 12    The Open Respiratory Medicine Journal, 2008, Volume 2  Domingo and Rubio 
  With these data, we calculated the maximum and mini-
mum figures of patients at the service to be: a) Maximum: 
Patients on HOT in the entire area + patients likely to re-
quire HOT in the short or medium term + frequently hospi-
talized patients = 223 + 111 + 92 = 426; b) Minimum: Pa-
tients on HOT followed at the hospital + patients controlled 
at the hospital and likely to require HOT in the short or me-
dium term (50% of 164) + frequently hospitalized patients = 
164 + 82 + 92 = 338. 
  So our patient total was likely to range between 300 and 
400. The final number of 289 patients indicates that the fit of 
capacity of the servuction was slightly lower than predicted. 
  4.3.2. Calculation of the number of scheduled appoint-
ments. This section refers to routine scheduling. 
  Our service operated three days per week. We predicted 
an average of 4 appointments per patient per year, though 
obviously some patients would require more frequent atten-
tion. Assuming the figure of 300 patients, with one appoint-
ment every three months, the number of scheduled appoint-
ments was 1,200 a year; that is, 109 a month (1,200 ap-
pointments/11 months), 25 a week, or 7-8 appointments a 
day. 
  4.3.3. Calculation of the number of non-scheduled ap-
pointments. This section refers to emergency visits. 
  This figure is very difficult to calculate. Nevertheless, we 
assumed that the mean would not be above one per day, 
bearing in mind that some consultations can be resolved 
satisfactorily by telephone and that decompensations are 
less common in the summer. 
  4.3.4. Total rate of appointments per day. scheduled 
visits plus emergency consultations = 8-9 visits / day. 
  4.3.5. Time management. Time devoted to the service by 
the physician and nurse.  
  4.3.6. Variability in seasonal demand. It is well known 
that consultations due to decompensations in patients with 
COPD are more frequent in winter. Furthermore, the law 
requires [37] that the indication of HOT should be reviewed 
annually. 
  To avoid overload at this service, we scheduled appoint-
ments for HOT and the renewal of authorization during the 
summer months, when fewer emergency consultations were 
expected. 
4.4. Management of Patient Flows and Modification of 
Demand 
  Almost immediately, the management of patient flows 
should keep the waiting list within acceptable limits. Patients 
referred to this service were filtered by a “gatekeeper”, either 
a hospital pneumologist in the case of hospitalized patients 
or the head of the pneumology service who prioritized refer-
rals from primary care. 
  The time management plan proved to be accurate, as the 
initial provisions were able to cover the demand both for 
scheduled examinations and for emergency care. Seasonal 
demand has a major effect on the design of a product of this 
type. De la Iglesia and cols [38] established in a study of 
232 patients that the number of admissions in winter was 
36.2%, spring 28%, summer 12.9% and autumn 22.8%. So 
the initial decision for scheduling the standard visits for 
HOT in the summer months when there was less pressure 
from emergency admissions also proved sensible. 
  In all, 3,589 consultations were made - some way below 
the predicted figure of around 4,800. It is difficult to estimate 
the number of emergency consultations because both in-
hospital visits and telephone consultations are classed to-
gether here: normally, of course, patients do not have access 
to an emergency phone number. 
4.5. Internal Marketing 
  For a new product, having too few clients is as serious a 
problem as having too many. The last logistical problem we 
should mention is the possible lack of support (due mainly to 
a lack of information) from other hospital or primary care 
doctors who might refer patients to this new service. 
  We acted at three different levels to raise our product’s 
profile. During a clinical session at the hospital we de-
scribed the service to the rest of the medical staff who might 
refer patients. In the program of clinical sessions at primary 
care centres in our reference area we included COPD and 
informed participants of the launch of this service. 
5. Evaluation of the Quality of the Servuction (Productiv-
ity Analysis) 
  As our evaluation criteria we decided to take the fit be-
tween the forecasts and the results for the number of visits 
(to assess the success of the planning of the new service) and 
a quality control of the new product. Post hoc analyses are 
always risky; the clinical and economic variables to evaluate 
must be clearly defined a priori. 
  To measure the quality of the model we assessed its clini-
cal effectiveness, its repercussion on patients’ quality of life 
and its efficiency (see below, paragraph 8). 
6. Clinical Design for Output Evaluation (Process 
Evaluation) 
-  The type of treatment should be clearly specified. The 
application of international regulations is always a 
guarantee of clarity. 
  The patients were treated according to a protocol 
based on the “Guidelines of the American Thoracic 
Society” [39] and the local government regulations 
[37] for the control of home oxygen therapy. 
-  The type of study must be defined. Studies of effec-
tiveness such as this one are often observational stud-
ies that evaluate cost minimization. 
  We performed an observational study with historical 
control. 
-  Duration and follow-up time must be clearly stated, 
as in any scientific study. 
  The study lasted 5 years and the follow-up period for 
patients was 1 year. 
Population 
  Determination of sample size: in our assessment of indi-
cators of effectiveness such as the number of emergency 
consultations and the number of hospitalisations, we calcu-
lated the sample of patients needed to draw conclusions. Design and Analysis of Health Products and Services  The Open Respiratory Medicine Journal, 2008, Volume 2    13 
  The experience of the research group, which observed a 
reduction similar to that recorded by other authors in the 
number of hospital admissions, was considered valid and 
reliable [40]. These data have been published elsewhere 
[35]. 
  Inclusion and exclusion criteria: these criteria have been 
defined elsewhere [35]. 
  The first important point in the design of this section is to 
establish the number of patients to evaluate. This is directly 
linked to the design of the study. We might have considered 
studying two groups of patients prospectively with two differ-
ent types of intervention: treatment at our new specialized 
service compared with the standard situation in the Spanish 
National Health Service which owes more to chance than to a 
clearly established plan. This design has the advantage of 
being prospective in both groups but the real clinical reliabil-
ity of the results might be difficult to extrapolate to other con-
texts since the control group may include many different types 
of medical care. In a recent publication Farrero and cols [41] 
studied 122 patients also followed up over a mean period of 1 
year. Their study differed from ours in that the patients were 
treated in two groups with different levels of intervention. 
Methodology 
  Patient recruitment: subjects were recruited from all pa-
tients referred and admitted to our specialized service. 
  Program and description of instruments used: described 
elsewhere [35]. 
7. Implementation of the Model 
  As specified in section 6, the model was implemented at 
the pneumology service of the CPT, which receives patients 
from both urban and rural environments. 
8. Evaluation of Results (Effectiveness and Efficiency 
Analysis) 
  The units of measurements were [35]:  
-  Number of visits forecast and visits performed during 
the period. 
 
-  Clinical variables: spirometry, arterial gasometry, 
carboxyhemoglobin, nº of admissions to the ward, 
emergencies, and days of hospitalization. 
-  Economic variables, both for the financer (the Cata-
lan Health Service, SCS) and for the provider (the 
hospital); mean cost of visits at hospital outpatient 
services, emergencies and hospitalisation, mean cost 
per patient, and aggregate costs. 
-  Assessment of quality of life using the Chronic Respi-
ratory Disease Questionnaire. 
 8.1.  Benefits  obtained.  They are specified elsewhere [35]. 
 Post  hoc  considerations. In the literature there are no data 
on this type of health care model and so it is impossible to 
carry out reliable comparisons. 
9. Conclusions 
  The conclusions should be based exclusively on the re-
sults of the product evaluated. 
  In our case we obtained the following conclusions: a) the 
design of this specialized was satisfactory; b) management of 
patients by a hospital pneumologist at this service was more 
effective and efficient than mixed management by a GP and 
a hospital specialist (pneumologist or internist and slowed 
down the deterioration in their quality of life. 
Post hoc considerations 
-  It is accepted today that many clinical decisions are 
the result of organizational habits or routines. There-
fore, the more clearly defined the area of action, the 
more consistent the treatment that health profession-
als provide for specific pathologies; the more closely 
they comply with international guidelines, the lower 
the variance in their performance (thus reducing the 
variations in medical practice-VMP-). In addition, the 
further down the ladder the clinical decisions are 
taken, the faster the organization responds - which in 
medical terms tends to avoid neglected represent 
greater effectiveness (Fig. 5) by avoiding neglences 
[42]. 
 
 
Fig. (5). 
EFFECTIVENESS
CHANGES IN HEALTH ORGANIZATIONS
MOVING THE DECISION DOWNWARDS:
The organization responds faster.
Less need for communication < loss of information.
Decisions are taken at a level with > technical information.
Lowers the administrative burden at higher levels.
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  There is a notable geographical variation in the con-
sumption of hospital resources both in Spain [43] and 
abroad [44]. Brook [45] and other authors attribute 
part at least of this variability of consumption of 
health services to organizational considerations. Our 
specialized service introduces notable improvements 
in this area. 
  Finally, since the criteria for referring patients to this 
specialized service were strictly medical, we believe that 
there is no risk of unfairness or the presence of influence 
costs, and the application of the “Eskimo economy” is also 
avoided [44]. The cost/opportunity ratio was also beneficial. 
10. Innovations Provided by the Model 
  In the final evaluation of a new health care model, the 
innovations it provides must be considered. 
  Our design: a) complied with the recommendations of the 
Dawson report, the design of the study takes full account of 
the needs of the population, identified thoroughly in two ear-
lier epidemiological studies performed between 1990 and 
1995; b) the care program for COPD patients incorporates 
the methodology of evidence-based medicine for clinical 
management; c) the new model represents an important 
qualitative change, by limiting access to the system (intro-
ducing gatekeeping at various levels of the health care orga-
nization); d) A clinical and economic evaluation (effective-
ness and efficiency) is presented of the improvements 
achieved by the new product; e)The behaviour of the new 
product is Paretian. 
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